PDT Partners, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 120 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,916,620
+36.8%
270,709
+36.0%
0.24%
+25.4%
Q2 2023$1,401,516
+52.1%
199,079
+80.2%
0.19%
+54.4%
Q1 2023$921,178
+31.8%
110,453
+81.4%
0.12%
+10.6%
Q4 2022$698,902
-13.5%
60,880
-5.1%
0.11%
-7.4%
Q3 2022$808,000
+96.1%
64,149
-25.9%
0.12%
+335.7%
Q2 2020$412,000
-42.6%
86,518
-33.0%
0.03%
-3.4%
Q2 2017$718,000
-33.8%
129,2000.0%0.03%
-49.1%
Q1 2017$1,085,000
+31.0%
129,200
-1.2%
0.06%
+5.6%
Q4 2016$828,000
+16.0%
130,794
-19.2%
0.05%
+28.6%
Q3 2016$714,000
-36.2%
161,900
+116.0%
0.04%
+44.8%
Q2 2015$1,119,000
+62.4%
74,960
+6.4%
0.03%
+61.1%
Q3 2014$689,000
-46.3%
70,474
-29.9%
0.02%
-47.1%
Q2 2014$1,282,000
+203.1%
100,514
+151.4%
0.03%
+240.0%
Q1 2014$423,000
-38.9%
39,974
-56.1%
0.01%
-88.0%
Q4 2013$692,000
+179.0%
91,100
+167.5%
0.08%
+1085.7%
Q3 2013$248,00034,0570.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders